New bioisosteric derivative of diclofenac sodium resolute gastric ulcer in rats through regulation of pro-inflammatory cytokines “Tumor necrosis factor alpha and Inter-leukin-1”
DOI:
https://doi.org/10.15218/zjms.2022.022Keywords:
Gastric ulcer, Bioisosteric, Diclofenac sodium, TN-α and IL-1βAbstract
Background and objective: Gastric ulcer is an important health risk for a human. It is a painful sore in the stomach lining. It is relatively easy to cure, but can cause significant problems if left un-treated. Non-steroidal anti-inflammatory drugs (NSAIDs) are prescribed for millions of people worldwide; however, as their consequences most of individuals suffer from gastric ulcers and related complications. Diclofenac sodium is a medication from NSAIDs class of drugs, is used to relieve joint pain from arthritis but when used chronically, it may cause bleeding and ulcers in the stomach or intestine. This study aimed to test the safety and the antiulcer activity of a new bioisosteric derivative of diclofenac sodium on a rat model.
Methods: 2-Cumaranone 1 had been utilized to prepare the propanamides 2a-e then after the bioisosteric diaryl ethers 3a-e synthesized; then its purity was characterized on the basis of IR, 1HNMR and Mass spectral data. Acute toxicity on albino mice was performed to ensure the safety and an experimental rat model was used to evaluate the anti-ulcer activity. Kidney and liver functions tests were measured, ulcer measurements were reported and pro-inflammatory cytokines tumor necrosis factor alpha (TNFα) and Interleukin 1 beta (IL-1β) levels were tested.
Results: Unlike diclofenac sodium, the bioisosteric diaryl ethers 3a-e is less acidic and produces less damage to the stomach wall. In addition, the structure of amide derivative is also bulky thus it is more selective to cyclooxygenase ΙΙ enzyme thus the risk of gastric ulcer was less than with diclofenac sodium itself.
Conclusion: Unlike diclofenac, amide derivative of diclofenac is less acidic than diclofenac thus it produces less damage to the stomach wall.
Metrics
References
Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications. Drug Safety. 2012; 35(12):1127–46. https://doi.org/10.2165/11633470-000000000-00000
Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016; 66(645): 172–3. https://doi.org/10.3399/bjgp16X684433
Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Research & Therapy. 2013; 15(3):1–10. https://doi.org/10.1186/ar4174
El-Shafei RA, Saleh RM. Pharmacological effects of vitamin C & E on diclofenac sodium intoxicated rats. Biomedicine & Pharmacotherapy. 2016; 84:314–22. https://doi.org/10.1016/j.biopha.2016.09.005
Bedos-Belval F, Rouch A, Vanucci-Bacqué C, Baltas M. Diaryl ether derivatives as anticancer agents–a review. Med Chem Comm. 2012; 3(11):1356–72. https://doi.org/10.1039/C2MD20199B
Ameen D, Snape TJ. Chiral 1, 1-diaryl compounds as important pharmacophores. Med Chem Comm. 2013; 4(6):893–907. https://doi.org/10.1039/C3MD00088E
Ameen DMH. Constructing chiral centres via O→ C aryl and acyl migrations: exploring reaction potential: University of Central Lancashire; 2014.
Frances DEA, Ingaramo PI, Ronco MT, Carnovale CE. Diabetes, an inflammatory process: oxidative stress and TNF-alpha involved in hepatic complication. J Biomed Sci Eng. 2013; 6:645–53. http://dx.doi.org/10.4236/jbise.2013.66079
Hammad DR, Elgazzar AG, Essawy TS, Abd El Sameie SA. Evaluation of serum interleukin-1 beta as an inflammatory marker in COPD patients. Egypt J Chest Dis Tuberc. 2015; 64:347–52. https://doi.org/10.1016/j.ejcdt.2015.01.005
Ameen D, Snape TJ. Developing the Scope of O→ C Aryl Migrations: Exploring Amide Substrates as Potential Precursors for Asymmetric Reactions. Eur J Org Chem. 2014; 2014(9):1925–34.2014. https://doi.org/10.1002/ejoc.201301716
Dhiyaaldeen SM, Amin ZA, Darvish PH, Mustafa IF, Jamil MM, Rouhollahi E, et al. Protective effects of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone chalcone in indomethacin-induced gastric erosive damage in rats. BMC Veterinary Research. 2014; 10(1):114. https://doi.org/10.1186/s12917-014-0303-7
Orinya OA, Adenkola AY, Ogbe RJ. Haematological and biochemical studies on the effect of diclofenac sodium on Wistar Rattus norvegicus. International Journal of Biological and Chemical Sciences. 2016; 10(5):2231–42. https://doi.org/10.4314/ijbcs.v10i5.23
Janićijević J, Krajišnik D, Čalija B, Vasiljević BN, Dobričić V, Daković A, et al. Modified local diatomite as potential functional drug carrier—A model study for diclofenac sodium. International Journal of Pharmaceutics. 2015; 496(2):466–74. https://doi.org/10.1016/j.ijpharm.2015.10.047
Ketuly KA, Hadi AHA, Golbabapour S, Hajrezaie M, Hassandarvish P, Ali HM, et al. Acute toxicity and gastroprotection studies with a newly synthesized steroid. PloS One. 2013; 8(3):e59296. https://doi.org/10.1371/journal.pone.0059296
Mahmood A, Fard AA, Harita H, Amin ZA, Salmah I. Evaluation of gastroprotective effects of Strobianthes crispus leaf extract on ethanol-induced gastric mucosal injury in rats. Scientific Research and Essays. 2011; 6(11):2306–14. https://doi.org/10.1155/2012/404012
Abdul-Aziz KK. Comparative evaluation of the anti-ulcer activity of curcumin and omeprazole during the acute phase of gastric ulcer. Food Nut Sci. 2011; 2:628–40. https://doi.org/10.4236/fns.2011.26088
Ott LW, Resing KA, Sizemore AW, Heyen JW, Cocklin RR, Pedrick NM, et al. Tumor Necrosis Factor-α-and Interleukin-1-Induced Cellular Responses: Coupling Proteomic and Genomic Information. Journal of Proteome Research. 2007; 6(6):2176–85. https://doi.org/10.1021/pr060665l
Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radical Biology and Medicine. 2007; 42(5):706–19. https://doi.org/10.1016/j.freeradbiomed.2006.12.011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Zahra Abdulqader Amin (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
